Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Teva Pharmaceutical Industries Ltd (TEVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,920,832
  • Shares Outstanding, K 1,016,877
  • Annual Sales, $ 18,854 M
  • Annual Income, $ -2,150,000 K
  • 60-Month Beta 1.34
  • Price/Sales 0.89
  • Price/Cash Flow 3.57
  • Price/Book 1.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.58
  • Number of Estimates 5
  • High Estimate 0.67
  • Low Estimate 0.51
  • Prior Year 0.91
  • Growth Rate Est. (year over year) -36.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.59 +8.47%
on 03/11/19
18.05 -6.32%
on 02/20/19
-1.11 (-6.16%)
since 02/19/19
3-Month
14.59 +15.90%
on 12/24/18
20.21 -16.33%
on 02/05/19
+0.62 (+3.81%)
since 12/19/18
52-Week
14.59 +15.90%
on 12/24/18
25.96 -34.86%
on 08/21/18
-1.00 (-5.58%)
since 03/19/18

Most Recent Stories

More News
Teva Pharmaceutical Industries Ltd. (TEVA) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $16.64, marking a +0.79% move from the previous day.

TEVA : 16.91 (+1.62%)
BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up

BioDelivery Sciences (BDSI) reports in-line loss in Q4. Sales beat the consensus mark. The company issues encouraging guidance for 2019.

ENDP : 8.77 (+2.10%)
CI : 172.78 (+3.39%)
BDSI : 4.94 (+0.61%)
TEVA : 16.91 (+1.62%)
Insys Plunges on Auditor's Concern About Insufficient Funds

Insys Therapeutics' (INSY) shares plunge after its auditor raises concerns related to insufficiency of funds to continue operations.

MYL : 28.62 (+1.56%)
ENDP : 8.77 (+2.10%)
INSY : 4.81 (+9.57%)
TEVA : 16.91 (+1.62%)
Why Regulations for Clinical Trials are Resulting in Streamlined Approval Process

Recent upgrades in international and domestic regulations regarding clinical trials, are both designed to protect patients, but also to upgrade the 'new normal' procedures in clinical trial quality and...

SANM : 30.29 (-0.26%)
CVRS : 2.26 (+12.44%)
TEVA : 16.91 (+1.62%)
VRAY : 8.10 (-0.86%)
PAVM : 1.03 (-1.90%)
SOLY : 7.30 (+17.55%)
Allergan Announces FDA Acceptance of Migraine Candidate NDA

Allergan's (AGN) new drug application seeking approval for its oral anti-CGRP candidate, ubrogepant, as acute treatment for migraine gets FDA acceptance. A decision is expected in Q4.

AGN : 154.10 (+2.16%)
LLY : 126.59 (+1.08%)
NVS : 92.99 (-0.19%)
TEVA : 16.91 (+1.62%)
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know

In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $15.78, marking a +0.19% move from the previous day.

TEVA : 16.91 (+1.62%)
Lilly's Emgality Gets FDA Priority Review for Cluster Headache

Eli Lilly's (LLY) supplemental biologics license application for its migraine drug, Emgality, wins a priority review from the FDA for treating episodic cluster headache in adults.

LLY : 126.59 (+1.08%)
TEVA : 16.91 (+1.62%)
AMGN : 191.49 (+0.09%)
PFE : 42.30 (+1.17%)
Investor Expectations to Drive Momentum within Amarin, PulteGroup, LivaNova, Teva Pharmaceutical Industries, Viad, and Activision Blizzard -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC (NASDAQ:AMRN),...

PHM : 26.24 (-1.61%)
AMRN : 18.86 (-2.28%)
LIVN : 95.29 (-0.08%)
VVI : 54.11 (+0.26%)
ATVI : 46.42 (+3.22%)
TEVA : 16.91 (+1.62%)
Teva Announces Launch of an Authorized Generic of Flector(R) Patch (diclofenac epolamine topical patch) in the United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of an authorized generic of Flector(R)1 Patch, 1.3 %, in the U.S.

TEVA : 16.91 (+1.62%)
Mylan (MYL) Q4 Earnings & Revenues Miss Estimates, Stock Down

Mylan (MYL) Q4 earnings and sales miss estimates due to persistent challenges in the North America segment. The guidance for 2019 was weak as well.

MYL : 28.62 (+1.56%)
TEVA : 16.91 (+1.62%)
RHHBY : 33.6950 (-0.49%)
GSK : 40.45 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade TEVA with:

Business Summary

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended...

See More

Key Turning Points

2nd Resistance Point 17.24
1st Resistance Point 17.08
Last Price 16.91
1st Support Level 16.72
2nd Support Level 16.52

See More

52-Week High 25.96
Fibonacci 61.8% 21.62
Fibonacci 50% 20.27
Fibonacci 38.2% 18.93
Last Price 16.91
52-Week Low 14.59

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar